Clofilium inhibits slick and slack potassium channels

Biologics: Targets and Therapy

Volumn 6, Issue , 2012, Pages 465-470

  Tejada, Maria de los Angeles ^a   Stolpe, Kathleen ^a   Meinild, Anne Kristine ^b   Klaerke, Dan A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clofilium; Potassium channel blockers; Slo2.1; Slo2.2

Indexed keywords

CLOFILIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; FEMALE; INHIBITION KINETICS; NONHUMAN; PHARMACOLOGICAL BLOCKING; POTASSIUM CONDUCTANCE; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; VOLTAGE CLAMP;

EID: 84872255364     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: 10.2147/BTT.S33827     Document Type: Article

References (21)

1. Shieh CC, Coghlan M, Sullivan J P, et al. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000;52(4):557-594.
2. Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov. 2009;8(12):982-1001.
3. Jenkinson DH. Potassium channels - multiplicity and challenges. Br J Pharmacol. 2006;147 Suppl 1:S63-S71.
4. Yuan A, Santi CM, Wei A, et al. The sodium-activated potassium channel is encoded by a member of the Slo gene family. Neuron. 2003;37:765-773.
5. Bhattacharjee A, Joiner WJ, Wu M, et al. Slick (Slo2.1), a rapidly-gating sodium-activated potassium channel inhibited by ATP. J Neurosci. 2003;23(37):11681-11691.
6. Bhattacharjee A, Gan L, Kaczmarek LK. Localization of the Slack potassium channel in the rat central nervous system. J Comp Neurol. 2002;454(3):241-254.
7. + channel Slick in the rat central nervous system. J Comp Neurol. 2005;484(1):80-92.
8. Zhang L, Sukhareva M, Barker JL, et al. Direct binding of estradiol enhances Slack (sequence like a calcium-activated potassium channel) channels' activity. Neuroscience. 2005;131(2):275-282.
9. Yang B, Gribkoff VK, Pan J, et al. Pharmacological activation and inhibition of Slack (Slo2.2) channels. Neuropharmacology. 2006;51(4):896-906.
10. Biton B, Sethuramanujam S, Picchione K, et al. The antipsychotic drug loxapine is an opener of the Na+-activated potassium channel Slack (Slo2.2). J Pharmacol Exp Ther. 2011;340 (3):706-715.
11. Dai L, Garg V, Sanguinetti MC. Activation of Slo2.1 channels by niflumic acid. J Gen Physiol. 2010;135(3):275-295.
12. + channels by cell volume changes. Pfugers Arch. 2002;444(1-2):167-177.
13. Gimenez-Gallego G, Navia MA, Reuben J P, et al. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci U S A. 1988;85(10):3329-3333.
14. Galvez A, Gimenez-Gallego G, Reuben JP, et al. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem. 1990;265(19):11083-11090.
15. Gessner G, Heinemann SH. Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241. Br J Pharmacol. 2003;138(1):161-171.
16. Malayev AA, Nelson DJ, Philipson LH. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel. Mol Pharmacol. 1995;47(1):198-205.
17. + channel in mouse heart. EMBO J. 1991;10(10):2805-2811.
18. Yang W P, Levesque PC, Little WA, et al. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A. 1997;94(8):4017-4021.
19. + current in mouse spermatozoa. Proc Natl Acad Sci U S A. 2011;108(14):5879-5884.
20. + channel mediates regulatory volume decrease response in a human bronchial epithelial cell line. Am J Physiol Cell Physiol. 2002;283(6): C1705-C1714.
21. Perry M, de Groot MJ, Helliwell R, et al. Structural determinants of HERG channel block by clofilium and ibutilide. Mol Pharmacol. 2004;66(2):240-249.